Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Roth Capital issued their Q1 2026 EPS estimates for shares of Aurora Cannabis in a report released on Thursday, February 6th.

Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...

It was a big day for Canadian cannabis stock Aurora Cannabis (TSE:ACB), as it posted its earnings report with a hefty ...

Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...

CA$31.6m (up from CA$24.2m loss in 3Q 2024). Profit margin: 36% (up from net loss in 3Q 2024). EPS: CA$0.57 (up from CA$0.51 ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

Investing.com -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB)在公布2025财年第三季度业绩后，股价大涨40%。这家总部位于Edmonton的公司报告显示收入和盈利能力显著提升，归功于其全球医用大麻业务和运营效率的提高。

From political maneuvering in Washington to major corporate developments across the global cannabis landscape, this week has ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...